Health Affairs, doi: 10.1377/hlthaff.27.4.w315 (Published online June 17, 2008) © 2008 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Google Scholar Articles by Culliton, B. J. PubMed PubMed Citation Articles by Culliton, B. J. Related Collections Related Article

Web Exclusives

Is Special FDA Regulation Of Nanomedicine Needed? A Conversation With Norris E. Alderson

¹ Norris Alderson is associate commissioner for science at the Office of Science and Health Coordination, Food and Drug Administration, in Rockville, Maryland. Barbara Culliton is a contributing editor at Health Affairs.

^*Corresponding author.

Abstract

Cutting-edge research in nanomedicine dominates studies in drug delivery, medical imaging, and the development of new devices. Materials and devices the size of molecules, and even individual atoms, make it possible to see a tumor when it is no more than a few atoms in size. By using material in this size range, drugs can go directly to tumors or inflamed arteries, bypassing healthy tissue. In this interview Norris Alderson of the Food and Drug Administration discusses the present and future state of nanomedicine as it applies to health care, taking into consideration benefits, risks, and how much is still unknown. [Health Affairs 27, no. 4 (2008): w315-w317 (published online 17 June 2008; 10.1377/hlthaff.27.4.w315)]

Key Words: Legal/Regulatory Issues, Pharmaceuticals, Research And Technology

                      What's this?

Related Article

• Barbara J. Culliton
  Nanomedicine—The Power Of Proteins: A Conversation With Lance Liotta And Emanual Petricoin
  Health Affairs, July/August 2008; 27(4): w310-w314.
  [Abstract] [Full Text] [PDF]